145 related articles for article (PubMed ID: 2194597)
1. Bone marrow transplantation utilizing HLA-matched unrelated marrow donors.
Gajewski J; Cecka M; Champlin R
Blood Rev; 1990 Jun; 4(2):132-8. PubMed ID: 2194597
[No Abstract] [Full Text] [Related]
2. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.
Beatty PG; Hansen JA; Longton GM; Thomas ED; Sanders JE; Martin PJ; Bearman SI; Anasetti C; Petersdorf EW; Mickelson EM
Transplantation; 1991 Feb; 51(2):443-7. PubMed ID: 1994541
[TBL] [Abstract][Full Text] [Related]
3. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of graft failure after human marrow transplantation: a review.
Hows JM
Immunol Lett; 1991 Jul; 29(1-2):77-80. PubMed ID: 1916930
[TBL] [Abstract][Full Text] [Related]
5. The immunogenetics of bone marrow transplantation.
Beatty PG
Transfus Med Rev; 1994 Jan; 8(1):45-58. PubMed ID: 8136607
[TBL] [Abstract][Full Text] [Related]
6. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
7. Selection of marrow donors for patients lacking an HLA-identical sibling.
Anasetti C; Beatty PG
Cancer Treat Res; 1990; 50():129-40. PubMed ID: 1976347
[No Abstract] [Full Text] [Related]
8. Histocompatibility and bone marrow transplantation (BMT).
Richter KV
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):445-50. PubMed ID: 2480287
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
[TBL] [Abstract][Full Text] [Related]
10. HLA-mismatched bone marrow transplantation in thalassemia.
Polchi P; Galimberti M; Lucarelli G; Baronciani D; Giardini C; Angelucci E; De Biagi M; Donati M
Bone Marrow Transplant; 1993; 12 Suppl 1():67-9. PubMed ID: 8374569
[No Abstract] [Full Text] [Related]
11. Results of allogeneic bone marrow transplantation with unrelated or mismatched donors.
Beatty PG
Semin Oncol; 1992 Jun; 19(3 Suppl 7):13-9. PubMed ID: 1615329
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation for patients with hematologic malignancies.
Buckner CD; Anasetti C; Bianco J; Nemunaitis J
Schweiz Med Wochenschr Suppl; 1991; 43():91-101. PubMed ID: 1726858
[TBL] [Abstract][Full Text] [Related]
14. Significance of MLC for BMT with serological HLA-identical related and unrelated donors.
Bonfichi M; Bernasconi P; Brera C; Boni M; Caldera C; Campagnoli C; Alessandrino EP; Bernasconi C
Bone Marrow Transplant; 1993; 11 Suppl 1():28-30. PubMed ID: 8448540
[No Abstract] [Full Text] [Related]
15. [Transplantation immunology in allogeneic bone marrow transplantation. The significance of HLA-tissue crossmatching between donors and recipients].
Egeland T; Thorsby E
Tidsskr Nor Laegeforen; 1994 Jan; 114(3):319-22. PubMed ID: 8191429
[TBL] [Abstract][Full Text] [Related]
16. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
17. [HLA serologically mismatched unrelated bone marrow transplantation].
Kato S
Rinsho Ketsueki; 2006 Jul; 47(7):587-8. PubMed ID: 16910567
[No Abstract] [Full Text] [Related]
18. Unrelated donor marrow transplantation in children: transplant policy and outcome in Leiden Paediatrics SCT-Centre.
Vossen JM; Donker AE; Heemskerk MB; Lie JL; van Weel-Sipman MH; Bredius RG; Bakker JD; Egeler RM; Oudshoorn M
Bone Marrow Transplant; 2010 Jan; 45(1):87-95. PubMed ID: 19448680
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation for leukemia utilizing HLA-matched unrelated donors.
Champlin R
Bone Marrow Transplant; 1993; 11 Suppl 1():74-7. PubMed ID: 8448555
[No Abstract] [Full Text] [Related]
20. Bone marrow transplantation in leukemia using family donors other than HLA-identical siblings: a preliminary report from the International Bone Marrow Transplant Registry.
Bortin MM
Transplant Proc; 1987 Feb; 19(1 Pt 3):2629-31. PubMed ID: 3274571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
